Invesco’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $941M | Sell |
15,509,999
-1,322,484
| -8% | -$77.1M | 0.09% | 184 |
|
|
2025
Q4 | $908M | Sell |
16,832,483
-793,597
| -5% | -$38.2M | 0.09% | 191 |
|
|
2025
Q3 | $795M | Sell |
17,626,080
-689,393
| -4% | -$32.2M | 0.13% | 169 |
|
|
2025
Q2 | $848M | Buy |
18,315,473
+852,317
| +5% | +$41.8M | 0.14% | 146 |
|
|
2025
Q1 | $1.07B | Buy |
17,463,156
+1,025,766
| +6% | +$59.8M | 0.2% | 92 |
|
|
2024
Q4 | $930M | Buy |
16,437,390
+242,186
| +1% | +$13.5M | 0.17% | 109 |
|
|
2024
Q3 | $838M | Buy |
16,195,204
+1,563,627
| +11% | +$73.4M | 0.16% | 130 |
|
|
2024
Q2 | $608M | Sell |
14,631,577
-2,223,481
| -13% | -$99.5M | 0.13% | 168 |
|
|
2024
Q1 | $914M | Buy |
16,855,058
+1,253,027
| +8% | +$63.8M | 0.2% | 95 |
|
|
2023
Q4 | $801M | Sell |
15,602,031
-4,556
| -0% | -$239K | 0.19% | 96 |
|
|
2023
Q3 | $906M | Buy |
15,606,587
+1,240,902
| +9% | +$76M | 0.24% | 62 |
|
|
2023
Q2 | $919M | Sell |
14,365,685
-369,668
| -3% | -$24.8M | 0.24% | 71 |
|
|
2023
Q1 | $1.02B | Sell |
14,735,353
-288,046
| -2% | -$20.3M | 0.28% | 53 |
|
|
2022
Q4 | $1.08B | Sell |
15,023,399
-3,723,858
| -20% | -$281M | 0.32% | 44 |
|
|
2022
Q3 | $1.33B | Buy |
18,747,257
+1,270,485
| +7% | +$92.2M | 0.43% | 23 |
|
|
2022
Q2 | $1.35B | Buy |
17,476,772
+578,586
| +3% | +$44.1M | 0.41% | 34 |
|
|
2022
Q1 | $1.23B | Sell |
16,898,186
-388,706
| -2% | -$26.1M | 0.31% | 46 |
|
|
2021
Q4 | $1.08B | Buy |
17,286,892
+1,555,800
| +10% | +$91.3M | 0.26% | 63 |
|
|
2021
Q3 | $931M | Buy |
15,731,092
+331,205
| +2% | +$21.8M | 0.24% | 76 |
|
|
2021
Q2 | $1.03B | Sell |
15,399,887
-1,608,299
| -9% | -$105M | 0.25% | 59 |
|
|
2021
Q1 | $1.07B | Sell |
17,008,186
-1,677,125
| -9% | -$104M | 0.29% | 48 |
|
|
2020
Q4 | $1.16B | Sell |
18,685,311
-2,522,611
| -12% | -$155M | 0.34% | 33 |
|
|
2020
Q3 | $1.28B | Sell |
21,207,922
-1,736,908
| -8% | -$105M | 0.43% | 26 |
|
|
2020
Q2 | $1.35B | Buy |
22,944,830
+324,520
| +1% | +$19.4M | 0.48% | 22 |
|
|
2020
Q1 | $1.26B | Sell |
22,620,310
-2,642,278
| -10% | -$162M | 0.53% | 20 |
|
|
2019
Q4 | $1.62B | Buy |
25,262,588
+346,940
| +1% | +$19.9M | 0.5% | 19 |
|
|
2019
Q3 | $1.26B | Buy |
24,915,648
+902,962
| +4% | +$42.4M | 0.33% | 46 |
|
|
2019
Q2 | $1.09B | Buy |
24,012,686
+6,915,526
| +40% | +$322M | 0.28% | 55 |
|
|
2019
Q1 | $816M | Buy |
17,097,160
+440,868
| +3% | +$22M | 0.28% | 67 |
|
|
2018
Q4 | $866M | Buy |
16,656,292
+1,642,965
| +11% | +$88.3M | 0.33% | 49 |
|
|
2018
Q3 | $932M | Sell |
15,013,327
-305,680
| -2% | -$18.1M | 0.29% | 61 |
|
|
2018
Q2 | $848M | Sell |
15,319,007
-492,565
| -3% | -$26.6M | 0.28% | 66 |
|
|
2018
Q1 | $1B | Buy |
15,811,572
+983,417
| +7% | +$63.3M | 0.37% | 42 |
|
|
2017
Q4 | $909M | Buy |
14,828,155
+36,958
| +0.2% | +$2.31M | 0.33% | 58 |
|
|
2017
Q3 | $943M | Buy |
14,791,197
+3,633,461
| +33% | +$212M | 0.35% | 50 |
|
|
2017
Q2 | $622M | Buy |
11,157,736
+1,686,197
| +18% | +$91.8M | 0.19% | 108 |
|
|
2017
Q1 | $515M | Buy |
9,471,539
+3,479,560
| +58% | +$191M | 0.17% | 130 |
|
|
2016
Q4 | $350M | Sell |
5,991,979
-403,026
| -6% | -$22M | 0.12% | 191 |
|
|
2016
Q3 | $345M | Sell |
6,395,005
-1,579,601
| -20% | -$101M | 0.12% | 196 |
|
|
2016
Q2 | $587M | Sell |
7,974,606
-614,739
| -7% | -$43.4M | 0.22% | 95 |
|
|
2016
Q1 | $549M | Sell |
8,589,345
-242,664
| -3% | -$15.3M | 0.22% | 96 |
|
|
2015
Q4 | $608M | Buy |
8,832,009
+605,347
| +7% | +$40M | 0.24% | 84 |
|
|
2015
Q3 | $487M | Sell |
8,226,662
-1,422,282
| -15% | -$90.2M | 0.21% | 101 |
|
|
2015
Q2 | $642M | Sell |
9,648,944
-1,972,011
| -17% | -$130M | 0.25% | 79 |
|
|
2015
Q1 | $750M | Buy |
11,620,955
+161,433
| +1% | +$10.1M | 0.29% | 67 |
|
|
2014
Q4 | $676M | Sell |
11,459,522
-2,808,185
| -20% | -$158M | 0.26% | 72 |
|
|
2014
Q3 | $730M | Buy |
14,267,707
+600,047
| +4% | +$30M | 0.29% | 60 |
|
|
2014
Q2 | $663M | Sell |
13,667,660
-3,144,218
| -19% | -$155M | 0.26% | 70 |
|
|
2014
Q1 | $873M | Buy |
16,811,878
+155,339
| +0.9% | +$8.27M | 0.35% | 44 |
|
|
2013
Q4 | $885M | Buy |
16,656,539
+1,304,479
| +8% | +$66.5M | 0.35% | 41 |
|
|
2013
Q3 | $710M | Buy |
15,352,060
+180,631
| +1% | +$7.93M | 0.31% | 59 |
|
|
2013
Q2 | $678M | Buy |
+15,171,429
| New | +$659M | 0.32% | 63 |
|
Other funds holding BMY
VCM
VPM
Invesco's BMY Position: Q1 2026 in Review
Invesco reduced its Bristol-Myers Squibb (BMY) stake by 7.9% in Q1 2026, selling an estimated $77.1M and leaving 15,509,999 shares worth $941M. The position accounts for 0.09% of the portfolio, ranked #184.
Invesco first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.62B in Q4 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Invesco held 15,509,999 shares of Bristol-Myers Squibb worth $941M as of Q1 2026.
- Invesco sold 1,322,484 Bristol-Myers Squibb shares in Q1 2026, an estimated $77.1M.
- Bristol-Myers Squibb made up 0.09% of Invesco's portfolio in Q1 2026, its #184 holding.
- Invesco first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Invesco's Bristol-Myers Squibb position peaked at $1.62B in Q4 2019.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.